In summary, YXS enhanced myocardial function, decreased BNP and ANP levels, and attenuated structure rupture and collagen deposition, through restoring Trx2 and inhibiting JNK and p38 activation in ischemia-induced HF. The gene discussed is NPPB; the disease is ischemia.